Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
First-in-human safety, pharmacokinetics, food-effect, multiple-dose, and elderly study of ABT-639
NL-OMON34223Phase 1Active, not recruiting
- Sponsor
- Abbott Laboratories
- Start
- May 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of ABT-639 in pain, sponsored by Abbott Laboratories. Started May 2010; status: active, not recruiting.
02
Drugs
ABT-639
03
Conditions
pain
Beyond the preview
Go deeper on NL-OMON34223.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON34223.